Filing Details
- Accession Number:
- 0001209191-14-077243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-22 09:37:47
- Reporting Period:
- 2014-12-18
- Filing Date:
- 2014-12-22
- Accepted Time:
- 2014-12-22 09:37:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1595097 | Corbus Pharmaceuticals Holdings Inc. | CRBP | Pharmaceutical Preparations (2834) | 464348039 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1451495 | F. Sean Moran | C/O Corbus Pharmaceuticals Holdings, Inc 100 River Ridge Drive Norwood MA 02062 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-18 | 18,800 | $3.36 | 31,350 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- All purchases were made between $3.25-$3.55 per share. The reporting person undertakes to provide to Corbus, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in this Form 4.